Azitra Correlations
| AZTR Stock | 0.31 0.01 3.33% |
The current 90-days correlation between Azitra Inc and Onconetix is 0.38 (i.e., Weak diversification). The correlation of Azitra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Azitra Correlation With Market
Modest diversification
The correlation between Azitra Inc and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Azitra Inc and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Azitra Stock
| 0.84 | RAC | Race Oncology | PairCorr |
| 0.84 | VALN | Valneva SE ADR | PairCorr |
| 0.79 | DRMA | Dermata Therapeutics Buyout Trend | PairCorr |
| 0.75 | AVH | Avita Medical | PairCorr |
| 0.87 | VINC | Vincerx Pharma, Common | PairCorr |
| 0.64 | VIVS | VivoSim Labs, Symbol Change | PairCorr |
| 0.83 | DYAI | Dyadic International | PairCorr |
| 0.76 | ALA | Arovella Therapeutics | PairCorr |
| 0.74 | VRAX | Virax Biolabs Group | PairCorr |
Moving against Azitra Stock
| 0.79 | VCEL | Vericel Corp Ord | PairCorr |
| 0.75 | DSGN | Design Therapeutics | PairCorr |
| 0.69 | VCYT | Veracyte | PairCorr |
| 0.65 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.64 | DNLI | Denali Therapeutics | PairCorr |
| 0.56 | DVAX | Dynavax Technologies Trending | PairCorr |
| 0.51 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.5 | 0P6S | Bayer AG NA | PairCorr |
| 0.49 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.43 | VERA | Vera Therapeutics | PairCorr |
| 0.42 | VKTX | Viking Therapeutics | PairCorr |
| 0.36 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.78 | VTVT | vTv Therapeutics | PairCorr |
| 0.76 | VRDN | Viridian Therapeutics | PairCorr |
| 0.56 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.46 | ENTA | Enanta Pharmaceuticals | PairCorr |
| 0.4 | EFTR | Effector Therapeutics | PairCorr |
| 0.37 | VXRT | Vaxart Inc | PairCorr |
Related Correlations Analysis
Risk-Adjusted Indicators
There is a big difference between Azitra Stock performing well and Azitra Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Azitra's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ONCO | 4.96 | (1.16) | 0.00 | (0.61) | 0.00 | 9.77 | 36.81 | |||
| JSPR | 3.83 | (0.49) | 0.00 | (0.22) | 0.00 | 6.55 | 20.79 | |||
| SPRC | 5.52 | (1.54) | 0.00 | (1.02) | 0.00 | 12.83 | 51.79 | |||
| SLXN | 3.44 | (0.75) | 0.00 | (0.26) | 0.00 | 7.84 | 28.60 | |||
| INDP | 6.56 | (0.27) | 0.00 | (0.02) | 0.00 | 18.70 | 37.41 | |||
| SCNI | 4.88 | (0.92) | 0.00 | (0.20) | 0.00 | 10.32 | 38.82 | |||
| SLRX | 5.96 | (2.36) | 0.00 | (3.55) | 0.00 | 10.05 | 66.01 | |||
| REVB | 2.86 | (0.87) | 0.00 | (0.36) | 0.00 | 5.26 | 19.41 | |||
| LIPO | 5.77 | (1.73) | 0.00 | (0.42) | 0.00 | 14.29 | 42.20 | |||
| ENVB | 7.89 | 0.02 | 0.01 | 0.08 | 10.67 | 24.21 | 121.83 |
Azitra Corporate Executives
Elected by the shareholders, the Azitra's board of directors comprises two types of representatives: Azitra inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Azitra. The board's role is to monitor Azitra's management team and ensure that shareholders' interests are well served. Azitra's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Azitra's outside directors are responsible for providing unbiased perspectives on the board's policies.